Cart
sales@molnova.com
Thiamine monophosphate chloride dihydrat
CAS No. 273724-21-3
Thiamine monophosphate chloride dihydrat( Aneurine monophosphate chloride )
Catalog No. M19701 CAS No. 273724-21-3
Thiamine monophosphate chloride dihydrat is a compound used in the screening of ligands that promote protein stability.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | 37 | In Stock |
|
Biological Information
-
Product NameThiamine monophosphate chloride dihydrat
-
NoteResearch use only, not for human use.
-
Brief DescriptionThiamine monophosphate chloride dihydrat is a compound used in the screening of ligands that promote protein stability.
-
DescriptionThiamine monophosphate chloride dihydrat is a compound used in the screening of ligands that promote protein stability.
-
In Vitro——
-
In Vivo——
-
SynonymsAneurine monophosphate chloride
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number273724-21-3
-
Formula Weight416.82
-
Molecular FormulaC12H22ClN4O6PS
-
Purity>98% (HPLC)
-
SolubilityWater:50mg/mL
-
SMILESO.O.[Cl-].Cc1c(CCOP(O)(O)=O)sc[n+]1Cc1cnc(C)nc1N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Stuetz W. Carrara V. McGready R. Lee S. Biesalski H. & Nosten F. (2012). Thiamine Diphosphate in Whole Blood Thiamine and Thiamine Monophosphate in Breast-Milk in a Refugee Population.?Plos ONE?7(6) e36280. doi: 10.1371/journal.pone.0036280
molnova catalog
related products
-
6,12,15-Trihydroxy-5...
6,12,15-Trihydroxy-5,8,11,13-abietetra-7-one
-
Gap19 TFA
Gap19 TFA is a peptide derived from nine amino acids of Cx43 cytoplasmic ring (CL), an effective, selective connexin 43 (Cx43) half-channel blocker.
-
Desmethoxy yangonin
Desmethoxy yangonin protects LPS or LPS/D-GalN-induced damages in cell or liver tissues mainly through de-regulating IKK/NFκB and Jak2/STAT3 signaling pathways.
